Reducing Health Disparities

Share

Cancer impacts everyone, but it doesn’t impact everyone equally. We are working to ensure everyone has a fair and just opportunity to prevent, find, treat, and survive cancer. No one should be disadvantaged in their fight against cancer because of how much money they make, the color of their skin, their sexual orientation, their gender identity, their disability status, or where they live.

From ensuring greater diversity among clinical trial participants to improving access to quality, affordable health care, we are asking lawmakers to reduce disparities in cancer care by advancing policies that break down existing barriers.

Black women are 40% more likely to die of breast cancer than white women overall

Latest Updates

September 30, 2025
Massachusetts

ACS CAN presented Medford’s Marina Watanabe with the Young Leader award in recognition of her passionate advocacy and commitment to ending cancer as we know it, for everyone.

September 24, 2025
Alabama

MONTGOMERY, Ala. – Patient advocacy groups including the American Cancer Society Cancer Action Network (ACS CAN) and ZERO Prostate Cancer applaud Alabama State Sen. Steve Livingston for pre-filing Senate Bill 19 , which eliminates cost sharing for lifesaving prostate cancer screenings for those covered by state-regulated insurance. The

August 18, 2025
National

More than 100 organizations representing millions of patients with serious health conditions and health care professionals sent a letter to Congress expressing their strong support for the Clinical Trial Modernization Act. Introduced in the House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-FL), the bipartisan legislation would help remove cost and geographic barriers to patient participation in clinical trials.

June 10, 2025
Massachusetts

Massachusetts cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine and patient navigation for all communities.

Reducing Health Disparities Resources

ACS CAN submitted comments to the U.S. Food and Drug Administration (FDA) on the Diversity Plans To Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials Draft Guidance for Industry. 

ACS CAN and more than 150 organizations representing patients, providers and health equity advocates sent a letter to Congress urging them to pass the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act into law to remove barriers to clinical trial enrollment.

Disparities have been described in various domains of cancer research, each issue exists separately and has a different relationship to understanding and addressing disparities in clinical outcomes. The various domains of research disparities are explored in Cancer Research and Disparities: Understanding and Addressing the Issues.